US2020101061A1PendingUtilityA1

4-oxoquinoline compound and use thereof as pharmaceutical agent

Assignee: JAPAN TOBACCO INCPriority: Nov 20, 2002Filed: May 10, 2019Published: Apr 2, 2020
Est. expiryNov 20, 2022(expired)· nominal 20-yr term from priority
C07D 409/06C07D 215/56A61P 31/00C07D 417/06A61K 31/5377A61K 31/47C07D 401/06C07D 215/58A61K 31/4375A61K 45/06A61K 31/4709A61P 31/18A61P 31/12A61P 43/00C07D 471/04
68
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An anti-HIV agent containing, as an active ingredient, a 4-oxoquinoline compound represented by the following formula [I] wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof. The compound of the present invention has HIV integrase inhibitory action and is useful as an anti-HIV agent for the prophylaxis or therapy of AIDS. Moreover, by a combined use with other anti-HIV agents such as protease inhibitors, reverse transcriptase inhibitors and the like, the compound can become a more effective anti-HIV agent. Since the compound has high inhibitory activity specific for integrases, it can provide a safe pharmaceutical agent with a fewer side effects for human.

Claims

exact text as granted — not AI-modified
1 - 41 . (canceled) 
     
     
         42 . A compound of the formula: 
       
         
           
           
               
               
           
         
       
     
     
         43 . A compound of the formula:

Join the waitlist — get patent alerts

Track US2020101061A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.